{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Lay of The Land","title":"#121: Michael Bruckman (Haima Therapeutics)","html":"","width":"100%","height":180,"duration":3522,"description":"Mike Bruckman, CEO of Haima Therapeutics.With a PhD in organic chemistry and additional training in biomedical engineering and management, Mike joined the founding team at Haima as CEO in 2018 and has led their commercialization. Having brought in over $13mm in government funding to support their program over the last 5 years, Haima was the sole team selected by DARPA to receive funding in pursuit of manufacturing a fully-dried whole-blood product.Haima is a biopharma Cleveland-based company developing cell and platelet-inspired therapies for the treatment of bleeding and a variety of other blood-related ailments where Haima’s initial focus is on the application of their platelet-inspired therapies to mitigate active bleeding and bleeding risks after traumatic injury, surgery, thrombocytopenia, and rare bleeding disorders. Haima’s lead technology, called SynthoPlate, is a novel, fully-synthetic hemostatic agent that mitigates bleeding by acting at the site of injury and amplifying your body’s natural clotting mechanisms.I learned a great deal from this conversation with Mike — we cover everything from his path from academia to entrepreneurship, to the basics of platelets and blood biology, to the vast implications that Haima’s synthetic platelet technology can have on the field of blood-related diseases. Please enjoy my conversation with Mike Bruckman.-----This episode is brought to you by airCFO — whose story we actually shared back on Episode 23 of Lay of The Land with airCFO’s founder and CEO, Justin McLoughlin! For many founders, dealing with finance and taxes is stressful, confusing, and time-consuming. Yet without paying proper attention to your finances and taxes, you won’t be able to produce accurate nor timely financials and forecasts for your team or investors. Even worse, if you miss critical tax deadlines, you'll get hit with unnecessary penalties from the IRS — these kinds of financial and tax missteps can jeopardize your entire startup and your...","thumbnail_url":"https://img.transistorcdn.com/83f-43Wz3A8u4303ZUZ8sIr3iY-45NuHaXW4rZCGBA0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE2MTMwLzE2Mjg3/MTAwMjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}